Crestchem Limited has announced key corporate developments following its recent board meeting. The company's Board of Directors convened on August 12, 2025, to review and approve financial results and make important personnel decisions.

Financial Results Approval

The board meeting, which commenced at 12:15 PM and concluded at 1:15 PM, saw the approval of unaudited standalone financial results for the quarter ended June 30, 2025. These results, prepared under Ind AS (Indian Accounting Standards), were accompanied by a limited review report in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

New Appointment

In a significant move, Crestchem Limited announced the appointment of Mr. Nitin S. Shah as the company's new Company Secretary, Compliance Officer, and Chief Financial Officer (CFO). Mr. Shah, who holds the ACS-7088 certification, assumed his new roles effective August 1, 2025. This appointment strengthens the company's leadership team and corporate governance structure.

Trading Window Closure

As part of its commitment to regulatory compliance, Crestchem Limited has implemented a trading window closure. This measure, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code, affects directors, officers, key managerial personnel, and designated persons. The trading window has been closed from July 1, 2025, and will remain so until 48 hours after the public disclosure of the quarterly results.

Corporate Governance

The company's actions, including the timely approval of quarterly results and the appointment of key personnel, demonstrate its commitment to maintaining strong corporate governance practices. These steps are aimed at ensuring transparency and compliance with regulatory requirements.

Crestchem Limited, with its corporate office in Ahmedabad and registered office in Mehsana, Gujarat, continues to focus on its operations while adhering to regulatory norms and enhancing its management structure.

Investors and stakeholders are advised to refer to the detailed financial results and limited review report for a comprehensive understanding of the company's performance for the quarter ended June 30, 2025.

Crestchem Limited has made two significant announcements that are likely to interest its shareholders and market observers.

Dividend Declaration

The company has declared a dividend of 10% per equity share, amounting to Rs. 1.00 per share, for the financial year 2024-25. This decision was made during a board meeting held on June 24, 2025. The Board of Directors has set the record date as August 13, 2025.

Shareholders who are listed as beneficial owners with the National Securities Depository Limited (NSDL) and Central Depository Securities Limited (CDSL) on the record date will be eligible to receive the dividend. This information was officially communicated to the BSE Limited on July 31, 2025.

New Appointment

In a separate announcement, Crestchem Limited has informed the BSE about a key management change. Mr. Nitin S. Shah (ACS: 07088) has been appointed as the new Company Secretary, Compliance Officer, and Chief Financial Officer (CFO) of the company. This appointment is effective from August 1, 2025.

Mr. Shah's appointment is in compliance with Section 203 of the Companies Act, 2013, and Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

About the New Appointee

Mr. Nitin S. Shah brings with him over 30 years of experience as a Company Secretary and Compliance Officer. He is a member of The Institute of Company Secretaries of India. The company has confirmed that Mr. Shah is not related to any of the directors of Crestchem Limited.

These developments indicate Crestchem Limited's commitment to shareholder returns and strengthening its corporate governance structure. Investors and market analysts will likely keep a close watch on how these changes might impact the company's performance and market position in the coming months.